Is InfuSystems Holdings Inc (INFU) overvalued? · P/E 25, rev $70.6M
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
This page asks whether InfuSystems Holdings Inc (INFU) looks expensive on cached numbers — not a short thesis.
Latest reported INFU revenue for 2026-06-30 was $70.6M. Net income was $4.2M. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
INFU currently screens at market cap $186.5M and trailing P/E 25.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next INFU 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the INFU stock page for the full model, not this heading.
Not investment advice.